Zum Hauptinhalt springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins
Buch von Stefan Barth (u. a.)
Sprache: Englisch

160,49 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:
Beschreibung
This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.
This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.
Inhaltsverzeichnis

Chemical Assembly of Antibody-Drug Conjugates.- Pre-clinical evaluation of ADCs delivering highly potent pyrrolobenzodiazepine (PBD) dimers.- Stable and homogeneous drug conjugation by sequential bis-alkylation at disulfide bonds using bis-sulfone reagents.- Calicheamicin antibody-drug conjugates for liquid- and solid tumor indications.- Enzyme-based strategies to generate site-specifically conjugated Antibody Drug Conjugates.- Substance P - Saporin for the Treatment of Intractable Pain.- Recombinant immunotoxins for Chronic Inflammatory Disease.- BL22: A milestone in targeting CD22.

Details
Erscheinungsjahr: 2017
Fachbereich: Toxikologie
Genre: Medizin
Rubrik: Wissenschaften
Medium: Buch
Reihe: Milestones in Drug Therapy
Inhalt: xi
181 S.
18 s/w Illustr.
39 farbige Illustr.
181 p. 57 illus.
39 illus. in color.
ISBN-13: 9783319468754
ISBN-10: 3319468758
Sprache: Englisch
Herstellernummer: 978-3-319-46875-4
Ausstattung / Beilage: HC runder Rücken kaschiert
Einband: Gebunden
Redaktion: Barth, Stefan
Grawunder, Ulf
Herausgeber: Ulf Grawunder/Stefan Barth
Auflage: 1st ed. 2017
Hersteller: Springer International Publishing
Milestones in Drug Therapy
Maße: 241 x 160 x 17 mm
Von/Mit: Stefan Barth (u. a.)
Erscheinungsdatum: 18.04.2017
Gewicht: 0,465 kg
Artikel-ID: 108969162
Inhaltsverzeichnis

Chemical Assembly of Antibody-Drug Conjugates.- Pre-clinical evaluation of ADCs delivering highly potent pyrrolobenzodiazepine (PBD) dimers.- Stable and homogeneous drug conjugation by sequential bis-alkylation at disulfide bonds using bis-sulfone reagents.- Calicheamicin antibody-drug conjugates for liquid- and solid tumor indications.- Enzyme-based strategies to generate site-specifically conjugated Antibody Drug Conjugates.- Substance P - Saporin for the Treatment of Intractable Pain.- Recombinant immunotoxins for Chronic Inflammatory Disease.- BL22: A milestone in targeting CD22.

Details
Erscheinungsjahr: 2017
Fachbereich: Toxikologie
Genre: Medizin
Rubrik: Wissenschaften
Medium: Buch
Reihe: Milestones in Drug Therapy
Inhalt: xi
181 S.
18 s/w Illustr.
39 farbige Illustr.
181 p. 57 illus.
39 illus. in color.
ISBN-13: 9783319468754
ISBN-10: 3319468758
Sprache: Englisch
Herstellernummer: 978-3-319-46875-4
Ausstattung / Beilage: HC runder Rücken kaschiert
Einband: Gebunden
Redaktion: Barth, Stefan
Grawunder, Ulf
Herausgeber: Ulf Grawunder/Stefan Barth
Auflage: 1st ed. 2017
Hersteller: Springer International Publishing
Milestones in Drug Therapy
Maße: 241 x 160 x 17 mm
Von/Mit: Stefan Barth (u. a.)
Erscheinungsdatum: 18.04.2017
Gewicht: 0,465 kg
Artikel-ID: 108969162
Warnhinweis

Ähnliche Produkte

Ähnliche Produkte